Division of Immunology and Rheumatology, Department of Medicine, Stanford University, Stanford, California, USA.
Department of Medicine, Palo Alto Veterans Administration Healthcare System, Palo Alto, California, USA.
J Clin Invest. 2021 Jun 1;131(11). doi: 10.1172/JCI143632.
With increasing age, individuals are more vulnerable to viral infections such as with influenza or the SARS-CoV-2 virus. One age-associated defect in human T cells is the reduced expression of miR-181a. miR-181ab1 deficiency in peripheral murine T cells causes delayed viral clearance after infection, resembling human immune aging. Here we show that naive T cells from older individuals as well as miR-181ab1-deficient murine T cells develop excessive replication stress after activation, due to reduced histone expression and delayed S-phase cell cycle progression. Reduced histone expression was caused by the miR-181a target SIRT1 that directly repressed transcription of histone genes by binding to their promoters and reducing histone acetylation. Inhibition of SIRT1 activity or SIRT1 silencing increased histone expression, restored cell cycle progression, diminished the replication-stress response, and reduced the production of inflammatory mediators in replicating T cells from old individuals. Correspondingly, treatment with SIRT1 inhibitors improved viral clearance in mice with miR-181a-deficient T cells after LCMV infection. In conclusion, SIRT1 inhibition may be beneficial to treat systemic viral infection in older individuals by targeting antigen-specific T cells that develop replication stress due to miR-181a deficiency.
随着年龄的增长,个体更容易受到病毒感染,如流感或 SARS-CoV-2 病毒。人类 T 细胞的一个与年龄相关的缺陷是 miR-181a 的表达减少。外周鼠 T 细胞中 miR-181ab1 的缺失导致感染后病毒清除延迟,类似于人类免疫衰老。在这里,我们表明,来自老年人的幼稚 T 细胞以及 miR-181ab1 缺陷型鼠 T 细胞在激活后会发生过度的复制应激,这是由于组蛋白表达减少和 S 期细胞周期进程延迟所致。组蛋白表达减少是由 miR-181a 的靶标 SIRT1 引起的,SIRT1 通过结合其启动子并减少组蛋白乙酰化来直接抑制组蛋白基因的转录。抑制 SIRT1 活性或沉默 SIRT1 会增加组蛋白表达,恢复细胞周期进程,减少复制应激反应,并减少衰老个体中复制 T 细胞中炎症介质的产生。相应地,用 SIRT1 抑制剂治疗可改善 LCMV 感染后 miR-181a 缺陷型 T 细胞小鼠的病毒清除。总之,通过靶向因 miR-181a 缺失而发生复制应激的抗原特异性 T 细胞,SIRT1 抑制可能有益于治疗老年人的全身性病毒感染。